Sichenzia Ross Ference represented Sunshine Biopharma in the offering.Sunshine Biopharma, Inc. finalized an underwritten public offering. The offering consisted of 1,882,353 units at a price to the public…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
